Guardant Health, Inc. (GH): Cash & Equivalents
$378.20M
As of 2025-12-31
$1.05B
As of 2026-06-30
+38.7%
3-year compound annual growth
-14.6%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $378.20M | -28.0% | 2026-02-19, Balance as of period end |
| 2024-12-31 | $525.54M | -53.6% | 2026-02-19, Balance as of period end |
| 2023-12-31 | $1.13B | +700.3% | 2026-02-19, Balance as of period end |
| 2022-12-31 | $141.65M | -71.2% | 2025-02-20, Balance as of period end |
| 2021-12-31 | $492.20M | -40.9% | 2024-02-22, Balance as of period end |
| 2020-12-31 | $832.98M | +481.6% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $143.23M | +1.9% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $140.54M | +94.4% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $72.28M | n/a | 2019-03-19, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Guardant Health, Inc. (GH) | 2025-12-31 | $378.20M | -28.0% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $796.27M | n/m |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $362.58M | +51.7% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $767.22M | +3.7% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $65.43M | -43.0% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $174.60M | +47.3% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $116.73M | -2.5% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $50.19M | -9.0% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $495.98M | +159.0% |
Compare GH, CAI, VCYT, RDNT side by side · Screen every company in Services-Medical Laboratories ↗